semaglutide prediabetes weight loss diabetes prevention trial Tirzepatide for Obesity Treatment and SELECT Trial

"Over 80% of Prior Auth Appeals SucceedWhy Aren't There More?" ama-assn.org Wilding JPH, et al

The evidence currently available indicates that GLP-1 RA could add to the arsenal available to address persistent gaps in the care of people living with T2DM with, or at the risk of, developing CKD and to reduce the residual renal risk present in those who have already developed CKD

Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission

That lawsuit was filed over what the OFA saw as an "arbitrary resolution of the tirzepatide injection shortage in October," according to the Alliance for Pharmacy Compounding

As a general rule, anything severe, persistent or simply worrying is worth flagging to a clinician early

Governor Maura Healey and the Group Insurance Commission have moved to end coverage for some FDA-approved weight-loss drugs, prompting strong opposition from major health organizations and patient advocates who say the decision could harm people living with obesity and widen health disparities